References
Elmezayen HA, Okabe H, Baba Y, Yusa T, Itoyama R, Nakao Y, et al. Clinical role of serum programmed death ligand 1 in patients with hepatocellular carcinoma: Where does it come from? Surg Today. (in press)
Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:112–9.
Chiriva-Internati M, Grizzi F, Bright RK, Martin Kast W. Cancer immunotherapy: avoiding the road to perdition. J Transl. Med. 2004;2:26.
Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, et al. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:2555–644.
Shirabe K, Bekki Y, Gantumor D, Araki K, Ishii N, Kuno A, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819–26.
Okabe H, Beppu T, Chikamoto A, Hayashi H, Yoshida M, Masuda T, et al. Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution. Int J Clin Oncol. 2014;19:614–21.
Okabe H, Beppu T, Hayashi H, Mima K, Nakagawa S, Kuroki H, et al. Rank classification based on the combination of indocyanine green retention rate at 15 min and (99m)Tc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection. Nucl Med Commun. 2014;35:478–83.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Hirohisa Okabe and other co-authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Okabe, H., Yamashita, Yi., Elmezayen, H.A. et al. Reply to the letter. Surg Today 50, 1320–1321 (2020). https://doi.org/10.1007/s00595-020-01999-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-020-01999-4